LONDON, UK Sun European Partners, LLP (“Sun European Partners”), the European adviser to Sun Capital Partners, Inc., announces that one of its affiliates has entered into an agreement to acquire NextPharma Technologies Holding Ltd (“NextPharma”), a global provider of contract manufacturing, product development, clinical trials and logistics services to the pharmaceutical and biotechnology industry. Terms of the transaction were not disclosed.
Headquartered in Surrey, UK, NextPharma offers a range of services spanning the entire drug development, manufacturing and distribution supply chain. The company is a leading outsourcing partner to the pharmaceutical, biotech and healthcare industries with seven manufacturing facilities, seven product development centres and six temperature-controlled storage and distribution sites across Europe and the U.S. NextPharma supports more than 200 customers including leading blue chip pharmaceutical and biotech companies.
Bill Wedlake, CEO of NextPharma commented: “For many years we have worked closely with our customers to develop a full range of integrated pharmaceutical development, manufacturing and logistics services to provide flexibility and confidence through high levels of quality and customer service. We are excited to work with Sun European Partners to continue to grow the company and to expand into innovative new technologies and markets.”
Matthias Gundlach, Vice President of Sun European Partners added: “The pharmaceutical industry is increasingly using drug development and manufacturing outsourcing. NextPharma, with its strong track record, reputation and state of the art facilities, is well positioned to capitalise on these trends. We see significant opportunity to grow the business both organically and by acquisitions and look forward to working with management to achieve this potential.”
About Sun European Partners, LLP Sun European Partners, LLP is the European adviser to Sun Capital Partners, Inc., a leading U.S.-based private investment firm focused on leveraged buyouts, equity, debt, and other investments in market-leading companies that can benefit from its in– house operating professionals and experience. Affiliates of Sun Capital Partners, Inc. have invested in more than 250 companies worldwide with combined sales in excess of $40 billion since the inception of Sun Capital Partners, Inc. in the U.S. in 1995. Sun Capital Partners, Inc. has offices in Boca Raton, Los Angeles, and New York, as well as affiliates with offices in London, Paris, Frankfurt, Luxembourg, Shanghai and Shenzhen. For more information, please visit www.SunEuropeanPartners.com.
Maitland +44(0)20 7379 5151 Anthony Silverman Rowan Brown
